![Steven Hyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Hyman
Directeur/Membre du Conseil chez
CYCLERION THERAPEUTICS, INC.
Fortune : 63 000 $ au 31/05/2026
Profil
Steven E.
Hyman is the founder of Emugen Therapeutics LLC.
Current jobs include Chairman at The Dana Foundation since 2018, Director at Janssen Pharmaceuticals, Inc., Director-Stanley Center Psychiatric Research at Massachusetts Institute of Technology since 2012, Director at Charles H.
Revson Foundation, Inc., Director-Stanley Center for Psychiatric Research at The Broad Institute, Inc. since 2012, Independent Director at Voyager Therapeutics, Inc. since 2015, Independent Director at Q-State Biosciences, Inc. since 2020, Independent Director at Cyclerion Therapeutics, Inc. since 2022, Member of the National Academy of Medicine (United States) since 2000, President of the American College of Neuropsychopharmacology since 2018, and Member of the National Academy of Sciences.
Former jobs include Director at National Institute of Mental Health from 1996 to 2001, Professor at Harvard University from 2001 to 2011, Member-Governing Board at The National Research Council from 2016 to 2018, President of the Society For Neuroscience, Strategic Advisor at Access BridgeGap Ventures, and President of the International Neuroethics Society from 2008 to 2013.
Education includes graduate degree from the University of Cambridge in 1976, doctorate from Harvard Medical School, and undergraduate degree from Yale College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 20 000 ( 0,46 % ) | 63 000 $ | 31/05/2026 | |
| 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Steven Hyman
| Sociétés | Poste | Début |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/09/2015 |
| CYCLERION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/07/2022 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 01/01/2012 |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | 01/01/2000 |
American College of Neuropsychopharmacology
 American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services Operates as a neuron psychopharmacology school | President | 01/01/2018 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Directeur/Membre du Conseil | - |
The Dana Foundation
 The Dana Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation/Endowment | Président | 01/12/2018 |
Charles H. Revson Foundation, Inc.
 Charles H. Revson Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Operates grant programs for urban affairs, Jewish life, biomedical research, and education | Directeur/Membre du Conseil | - |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Directeur/Membre du Conseil | 01/01/2014 |
| ░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Steven Hyman
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Steven Hyman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy consulting and advice | Commercial Services |
National Institute of Mental Health
 National Institute of Mental Health General GovernmentGovernment Promotes programs for the prevention of mental illnesses | Government |
Society For Neuroscience
 Society For Neuroscience Miscellaneous Commercial ServicesCommercial Services Operates brain and nervous system professional society for scientists & physicians | Commercial Services |
Charles H. Revson Foundation, Inc.
Charles H. Revson Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Operates grant programs for urban affairs, Jewish life, biomedical research, and education | Commercial Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Dana Foundation
The Dana Foundation Investment Trusts/Mutual FundsMiscellaneous Foundation/Endowment | Miscellaneous |
Access BridgeGap Ventures
 Access BridgeGap Ventures Investment ManagersFinance Access Bridgegap Ventures seeks to bridge the early-stage investment gap in the therapeutics space. The firm leverages their experience in start-up creation, technology commercialization and venture investing to fund young start-ups and create de novo spin-offs around potential high-impact technologies, many of which are still in academic research labs. | Finance |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Yale College
 Yale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services Operates as a neuron psychopharmacology school | Commercial Services |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Health Technology |
International Neuroethics Society
 International Neuroethics Society The International Neuroethics Society is an interdisciplinary organization dedicated to the responsible use of brain technology and the ethical, legal, clinical, social, and policy issues arising from advances in neuroscience. The private company is based in Bethesda, MD. It comprises members from over 35 countries, including neuroethicists, neuroscientists, philosophers, clinicians, lawyers, psychologists, engineers, industry professionals, and students. The society fosters neuroethics research, dialogue, and education through programs such as annual meetings, webinars, essay contests, mentoring, networking, internships, and awards. It publishes two official journals that address clinical, ethical, social, legal, and philosophical aspects of neuroscience. The society’s governance includes a board of directors and multiple committees responsible for strategic initiatives, membership, program planning, engagement, and support for early career members. | |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Emugen Therapeutics LLC |
Choisissez Zonebourse 
